Author: Khadija Abbasi, Child Psychologist , Speech Language Pathologist
Tylenol (also known as panadol/paracetamol or acetaminophen) is one of the most commonly used pain and fever medications during pregnancy. It is generally considered safer than alternatives like non-steroidal anti-inflammatory drugs (NSAIDs), especially in the later stages of pregnancy. However, because tylenol crosses the placenta, the developing fetus is exposed whenever the mother takes it. This has led to growing concern about its potential impact on long-term child development.
Potential Links to Autism and ADHD
Recent large-scale epidemiological studies and systematic reviews have reported small but consistent associations between prenatal Tylenol use and an increased risk of neurodevelopmental disorders, particularly attention- deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). While these findings suggest a possible relationship, they do not prove that acetaminophen causes these conditions. The observed associations may be influenced by other factors, such as genetics, maternal health, or environmental exposures.
Proposed Biological Mechanisms
although a definitive causal link has not been established in humans, experimental research has proposed several biological mechanisms by which Tylenol could potentially affect fetal brain development. These include oxidative stress, mitochondrial dysfunction, and disruption of hormonal and endocannabinoid systems — all of which play key roles in neural and reproductive development.
There is evidence suggesting that Tylenol can act as an endocrine disruptor – a substance that interferes with hormone production or activity. For example, it may affect thyroid hormone levels, which are essential for brain development, especially in early gestation. This medication is mainly broken down in the liver. During this process, a small amount of a harmful substance called NAPQI is made. Normally, the body uses an antioxidant called glutathione to get rid of NAPQI. However, if someone takes too much acetaminophen or uses it for a long time, the glutathione levels drop. This causes NAPQI to build up in the liver. The buildup of NAPQI can lead to oxidative stress, which damages cells. It can also attach to proteins in the mitochondria, which are the energy-producing parts of cells. This attachment and damage can make it harder for the mitochondria to produce energy properly, leading to liver cell injury.
Regulatory and Clinical Guidance
Regulatory agencies, including the U.S. Food and Drug Administration (FDA), have acknowledged the potential risks but emphasize that current evidence is inconclusive. The FDA has issued safety communications highlighting the need for caution. Similarly, the American College of Obstetricians and Gynecologists (ACOG) continues to recommend acetaminophen as the preferred pain and fever treatment during pregnancy but advises using the lowest effective dose for the shortest possible time.
The World Health Organization (WHO) and other international bodies have echoed this cautious approach. Some research has found that higher concentrations of tylenol in umbilical cord blood are associated with a greater likelihood of ASD